MODERNA BIOTECH DISTRIBUTOR UK LTD maintains an average payment time of 31 days, sitting marginally outside the standard 30-day threshold. While 56% of payments are made within 30 days, a significant 38% fall within the 31–60 day band, indicating a consistent pattern of slight delays rather than isolated late payments. The 6% of payments exceeding 60 days suggests occasional but notable extended delays that could impact cash flow planning.
With 34% of payments classified as late, the company presents a moderately unreliable payment profile, meaning roughly one in three invoices will not be settled on time. The concentration of delays in the 31–60 day range points to a systematic, recurring payment behaviour rather than random or exceptional circumstances. This level of predictability, while not optimal, does allow suppliers to anticipate a likely settlement window of 30–60 days in most cases.
MODERNA BIOTECH DISTRIBUTOR UK LTD represents a moderate payment risk, acceptable for continued supply but warranting active credit management. Suppliers should consider implementing 30-day payment terms with clear late payment clauses, and may wish to set credit limits reflective of the 31–60 day settlement reality. Proactive invoice chasing at the 25-day mark and periodic account reviews are recommended to mitigate exposure given the 34% late payment rate.
| Reporting Period | Filing Date | Average Time to Pay (days) | Paid within 30 days | Paid 31-60 days | Paid after 60 days | Not Paid within Terms |
|---|---|---|---|---|---|---|
| 01 Jul 2025 - 31 Dec 2025 | 02 Feb 2026 | 31 | 56% | 38% | 6% | 34% |
| 01 Jan 2025 - 30 Jun 2025 | 30 Jul 2025 | 72 | 26% | 42% | 32% | 53% |
This information is as reported by the business, and responses are in their own words.
Standard payment terms
Net 60 for regular companies, Net 0 for healthcare professionals, government entities, insurance companies. These payment terms apply unless specifically stated in the agreement or the SOW.
Were there any changes to the standard payment terms in the reporting period?
No information available
Any other information about payment terms
No additional information
Maximum contractual payment period agreed
0
In case of unpaid invoice – supplier contacts accountspayable@modernatx.com who is responsible for payment terms verification and preparing payment as soon as possible In case of quality/quantity/price difference – invoice is rejected back to supplier’s contact address by Accounts Payable based on order owner’s comment with a standard notification (wording may be slightly different depending on rejection reason): Dear Supplier, please be informed that your invoice has been rejected by order owner due to quality/quantity/price difference. Please contact your Moderna Business Contact to explain the difference. Amended invoice please resubmit to invoice@modernatx.com. Thank you for your understanding. Kind Regards, Moderna Accounts Payable Team
Has this business signed up to a code of conduct or standards on payment practices?
For example, signatories to The Prompt Payment Code must commit to paying 95% of their invoices within 60 days.
❌
Does this business offer e-invoicing in relation to qualifying contracts?
This is where suppliers can electronically submit and track invoices. It's not just allowing suppliers to email them an invoice.
❌
Does this business offer supply chain finance?
This is where a supplier who has submitted an invoice can be paid by a third-party finance provider earlier than the agreed payment date. The business would then pay the finance provider the invoiced sum.
❌
Under its payment practices and policies, can this business deduct sums from payments under qualifying contracts as a charge for remaining on a supplier list?
❌
During the reporting period, did the business deduct sums from payments as a charge for remaining on a supplier list?
No information available
MODERNA BIOTECH DISTRIBUTOR UK LTD is a private limited company operating within the biotechnology distribution sector in the United Kingdom. The company focuses on the distribution of biotech products and related materials, functioning as a key intermediary within the UK's life sciences and biotechnology supply chain.
The company was incorporated on 28 June 2022 and holds company registration number 14200885 with Companies House. Its registered office is located at 54 Portland Place, London, W1B 1DY, placing it within one of London's established professional and commercial districts.
Biotechnology distributors of this nature typically manage the procurement, storage, and distribution of biological products, reagents, pharmaceutical materials, and related biotech supplies to clients across healthcare, research, and commercial sectors in the UK. Such organisations serve as essential links between biotech manufacturers and end users, including laboratories, research institutions, and healthcare providers.
As an active private limited company, MODERNA BIOTECH DISTRIBUTOR UK LTD operates under the regulatory framework governing UK private limited companies, maintaining its obligations to Companies House in accordance with UK company law.